14-20584315-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145250.5(RNASE11):c.160A>G(p.Asn54Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000265 in 1,614,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N54S) has been classified as Uncertain significance.
Frequency
Consequence
NM_145250.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNASE11 | NM_001394189.1 | c.160A>G | p.Asn54Asp | missense_variant | Exon 3 of 3 | NP_001381118.1 | ||
RNASE11 | NM_001394190.1 | c.160A>G | p.Asn54Asp | missense_variant | Exon 3 of 3 | NP_001381119.1 | ||
RNASE11 | NM_001394191.1 | c.160A>G | p.Asn54Asp | missense_variant | Exon 3 of 3 | NP_001381120.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000398 AC: 100AN: 251362Hom.: 0 AF XY: 0.000375 AC XY: 51AN XY: 135854
GnomAD4 exome AF: 0.000261 AC: 381AN: 1461848Hom.: 0 Cov.: 33 AF XY: 0.000235 AC XY: 171AN XY: 727226
GnomAD4 genome AF: 0.000302 AC: 46AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.160A>G (p.N54D) alteration is located in exon 3 (coding exon 1) of the RNASE11 gene. This alteration results from a A to G substitution at nucleotide position 160, causing the asparagine (N) at amino acid position 54 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at